Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

324

Participants

Timeline

Start Date

May 7, 2014

Primary Completion Date

February 28, 2022

Study Completion Date

May 31, 2022

Conditions
Non-small Cell Lung Cancer
Interventions
RADIATION

Stereotactic Body Radiotherapy (SBRT)

RADIATION

Conventional Radiotherapy (CRT)

Trial Locations (16)

Unknown

Tom Baker Cancer Centre, Calgary

Cancer Care Manitoba, Winnipeg

Horizon Health Network, Saint John

Juravinski Hospital and Cancer Centre, Hamilton

London Regional Cancer Program at London Health Sciences Centre, London

Niagara Health System-Walker Family Cancer Centre, St. Catharines

Thunder Bay Regional Health Sciences Centre, Thunder Bay

Windsor Regional Cancer Centre, Windsor

CHUM Hospital Notre Dame, Montreal

Hôpital Maisonneuve-Rosemont, Montreal

Montreal General Hospital McGill, Montreal

Saskatoon Cancer Centre, Saskatoon

T6G 1Z2

Cross Cancer Institute, Edmonton

K7L 2V7

Cancer Centre of Southeastern Ontario at the Kingston General Hospital, Kingston

J4V 2H1

Charles LeMoyne Hospital, Greenfield Park

S4T 7T1

Allan Blair Cancer Centre, Regina

All Listed Sponsors
collaborator

Canadian Cancer Society (CCS)

OTHER

lead

Ontario Clinical Oncology Group (OCOG)

OTHER

NCT01968941 - Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients | Biotech Hunter | Biotech Hunter